Forskningspulje 2016 PhD-afhandlinger A novel marker of brain serotonin as predictor of response to antidepressive therapy Does Glucagon-like Peptide 1 (GLP-1) stimulation reduce alcohol intake in patients with alcohol dependence Dopamine Synthesis Capacity measured with (18F)-DOPA-PET Effects of erythropoietin (EPO) on cognitive side-effects of electroconvulsive therapy (ECT) (EPO-T Study) Glutamatergic and GABAergic disturbances in individuals at ultra-high risk of psychosis. Implications for clinical and functional outcome Neural correlates of error monitoring and error adaption in children at high risk for schizophrenia and bipolar disorder Preventing psychosis. Improving brain networks in Ultra High Risk subjects by means of psychological interventions TRANS-diagnostic Cognitive behavioral Therapy versus standard cognitive behavioral therapy (TRACT-RCT). Targeting Neuroticism Post.doc-projekter Internetwork brain dynamics in children at high genetic risk for schizophrenia and bipolar disorder The role of central Glucagon-like peptide-1 receptors in impulsive to compulsive drug taking behavior
PhD-afhandlinger A novel marker of brain serotonin as predictor of response to antidepressive therapy Does Glucagon-like Peptide 1 (GLP-1) stimulation reduce alcohol intake in patients with alcohol dependence Dopamine Synthesis Capacity measured with (18F)-DOPA-PET Effects of erythropoietin (EPO) on cognitive side-effects of electroconvulsive therapy (ECT) (EPO-T Study) Glutamatergic and GABAergic disturbances in individuals at ultra-high risk of psychosis. Implications for clinical and functional outcome Neural correlates of error monitoring and error adaption in children at high risk for schizophrenia and bipolar disorder Preventing psychosis. Improving brain networks in Ultra High Risk subjects by means of psychological interventions TRANS-diagnostic Cognitive behavioral Therapy versus standard cognitive behavioral therapy (TRACT-RCT). Targeting Neuroticism
Post.doc-projekter Internetwork brain dynamics in children at high genetic risk for schizophrenia and bipolar disorder The role of central Glucagon-like peptide-1 receptors in impulsive to compulsive drug taking behavior